(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of 3% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Wave Life Sciences's revenue in 2025 is $108,302,000.On average, 7 Wall Street analysts forecast WVE's revenue for 2025 to be $9,325,964,122, with the lowest WVE revenue forecast at $5,310,616,327, and the highest WVE revenue forecast at $15,340,927,799. On average, 6 Wall Street analysts forecast WVE's revenue for 2026 to be $14,422,774,421, with the lowest WVE revenue forecast at $3,599,247,192, and the highest WVE revenue forecast at $24,250,791,318.
In 2027, WVE is forecast to generate $17,830,164,088 in revenue, with the lowest revenue forecast at $5,065,038,693 and the highest revenue forecast at $34,196,685,479.